Your browser doesn't support javascript.
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant.
Abu-Raddad, Laith J; Chemaitelly, Hiam; Ayoub, Houssein H; Yassine, Hadi M; Benslimane, Fatiha M; Al Khatib, Hebah A; Tang, Patrick; Hasan, Mohammad R; Coyle, Peter; AlMukdad, Sawsan; Al Kanaani, Zaina; Al Kuwari, Einas; Jeremijenko, Andrew; Kaleeckal, Anvar Hassan; Latif, Ali Nizar; Shaik, Riyazuddin Mohammad; Abdul Rahim, Hanan F; Nasrallah, Gheyath K; Al Kuwari, Mohamed Ghaith; Butt, Adeel A; Al Romaihi, Hamad Eid; Al-Thani, Mohamed H; Al Khal, Abdullatif; Bertollini, Roberto.
  • Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.
  • Chemaitelly H; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.
  • Ayoub HH; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA.
  • Yassine HM; Department of Public Health, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Benslimane FM; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.
  • Al Khatib HA; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.
  • Tang P; Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar.
  • Hasan MR; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Coyle P; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • AlMukdad S; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Al Kanaani Z; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Al Kuwari E; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Jeremijenko A; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Kaleeckal AH; Department of Pathology, Sidra Medicine, Doha, Qatar.
  • Latif AN; Department of Pathology, Sidra Medicine, Doha, Qatar.
  • Shaik RM; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Abdul Rahim HF; Hamad Medical Corporation, Doha, Qatar.
  • Nasrallah GK; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom.
  • Al Kuwari MG; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.
  • Butt AA; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.
  • Al Romaihi HE; Hamad Medical Corporation, Doha, Qatar.
  • Al-Thani MH; Hamad Medical Corporation, Doha, Qatar.
  • Al Khal A; Hamad Medical Corporation, Doha, Qatar.
  • Bertollini R; Hamad Medical Corporation, Doha, Qatar.
Clin Infect Dis ; 75(1): e1188-e1191, 2022 Aug 24.
Article in English | MEDLINE | ID: covidwho-2017770
ABSTRACT
Beta (B.1.351)-variant coronavirus disease 2019 (COVID-19) disease was investigated in Qatar. Compared with the Alpha (B.1.1.7) variant, odds (95% confidence interval) of progressing to severe disease, critical disease, and COVID-19-related death were 1.24-fold (1.11-1.39), 1.49-fold (1.13-1.97), and 1.57-fold (1.03-2.43) higher, respectively, for the Beta variant.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Variants Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Variants Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid